Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-23-016362

Chief Medical Officer sold 1,187 shares at $21.87 ($25,960)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Eisner Mark Chief Medical Officer 2023-03-02 Sale −1,187 $21.87 $25,960 172,496 D: show line 1 in the form
Open-market sales · 1,187 sh · avg $21.87 · $25,960
Loading xslF345X03/doc4.xml…